First test of new shot aims to fight obesity
NCT ID NCT07142707
Summary
This is the first study in people to test a new drug called MBX 4291 for obesity. Researchers will give the drug as an injection under the skin to 64 adults with obesity to check if it is safe and how the body handles it. The main goal is to see what side effects people experience and to find the right dose for future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MBX Biosciences Investigational Site
RECRUITINGKnoxville, Tennessee, 37920, United States
Conditions
Explore the condition pages connected to this study.